IM Risperidone Cannot Be Given to Patients on 4 mg Oral Risperidone
Risperidone is only available as an oral formulation for acute treatment; there is no immediate-release IM risperidone injection available for routine use. The confusion likely stems from the existence of long-acting injectable (LAI) risperidone formulations, which serve an entirely different purpose and cannot be used interchangeably with oral therapy.
Understanding Risperidone Formulations
Oral Risperidone (What Your Patient is Currently Taking)
- Immediate-release tablets for daily administration
- The 4 mg daily dose your patient receives provides steady therapeutic levels through daily dosing
- Available as standard tablets or orally disintegrating tablets (ODT) [@1,@2,1]
Long-Acting Injectable Risperidone (NOT for Acute Use)
The only injectable risperidone formulations are long-acting preparations designed for maintenance treatment, not acute symptom management:
Risperidone LAI (Risperdal Consta®):
- Administered every 2 weeks intramuscularly (gluteal or deltoid)
- Requires 3 weeks of continued oral risperidone supplementation after the first injection because therapeutic release doesn't begin until week 3 [@12,@13,2]
- Reaches steady-state only after 4 injections (8 weeks)
- Conversion from 4 mg oral: would receive 25 mg IM every 2 weeks 3
Newer LAI Formulations:
- Risperidone ISM®: Monthly injection with faster onset (therapeutic levels within 12-24 hours), but still designed for maintenance, not acute use [@16,@19@]
- RBP-7000: Monthly subcutaneous injection [@22@]
When LAI Risperidone Can Be Initiated
Long-acting injectable risperidone is appropriate for:
- Maintenance treatment in patients stabilized on oral risperidone who have adherence issues
- Transition from oral therapy when the patient is clinically stable (not acutely agitated or in crisis)
- Prevention of relapse in patients with history of non-adherence [@11@]
Critical caveat: The patient must continue taking their oral risperidone (4 mg daily) for at least 3 weeks after the first LAI injection to maintain therapeutic levels [@12,2]
For Acute Agitation: Use Different Agents
If your patient requires immediate IM medication for acute agitation, risperidone is not an option. Guidelines recommend [@4,@5,4]:
First-line IM options:
- Haloperidol 5 mg IM (can repeat every 30-60 minutes)
- Olanzapine 10 mg IM (onset within 15-30 minutes)
- Ziprasidone 10-20 mg IM (can repeat every 2-4 hours)
- Lorazepam 2 mg IM (often combined with haloperidol)
For cooperative patients:
- Oral risperidone 2 mg + lorazepam 2 mg is as effective as IM haloperidol + lorazepam for agitation 4
Bottom Line
There is no circumstance where a patient on 4 mg oral risperidone can receive an "IM risperidone injection" as an acute intervention. If considering transition to LAI for maintenance therapy, this requires careful planning with 3 weeks of oral supplementation, not an acute switch.